BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Su J, Li J, Yu Q, Xu X, Wang J, Yang J, Li X, Chen X. Association of PON1 gene promoter DNA methylation with the risk of Clopidogrel resistance in patients with coronary artery disease. J Clin Lab Anal 2019;33:e22867. [PMID: 30891852 DOI: 10.1002/jcla.22867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Yang J, Yu Q, Chen L, Shi X, Su J, Zhu K. The DNAm levels of CREB5 (cg11301281) were associated with clopidogrel resistance. J Clin Lab Anal 2022;:e24690. [PMID: 36087301 DOI: 10.1002/jcla.24690] [Reference Citation Analysis]
2 Almohideb M. Safety and efficacy of nivolumab compared with other regimens in patients with melanoma: A network meta-analysis. Medicine 2022;101:e29390. [DOI: 10.1097/md.0000000000029390] [Reference Citation Analysis]
3 Li W, Wang Y, Huang R, Lian F, Xu G, Wang W, Xue S. Association of lipid metabolism-related gene promoter methylation with risk of coronary artery disease. Mol Biol Rep 2022. [PMID: 35941416 DOI: 10.1007/s11033-022-07789-0] [Reference Citation Analysis]
4 V Aswathy SP, Chandra KR, Jyothikrishna P, Arun KP. Dosage optimization of clopidogrel via a precision medicine approach: the way forward. Pharmacogenomics 2022;23:195-206. [PMID: 35112572 DOI: 10.2217/pgs-2020-0198] [Reference Citation Analysis]
5 Connelly PW, Yan AT, Nash MM, Wald RM, Lok C, Gunaratnam L, Kirpalani A, Prasad GVR. The Increase in Paraoxonase 1 Is Associated With Decrease in Left Ventricular Volume in Kidney Transplant Recipients. Front Cardiovasc Med 2021;8:763389. [PMID: 34926614 DOI: 10.3389/fcvm.2021.763389] [Reference Citation Analysis]
6 Mahrooz A, Mackness M. Epigenetics of paraoxonases. Curr Opin Lipidol 2020;31:200-5. [PMID: 32487820 DOI: 10.1097/MOL.0000000000000687] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Su J, Yu Q, Yang J, Zheng N, Zhong J, Ji L, Li J, Chen X. The association of polymorphisms in related circadian rhythm genes and clopidogrel resistance susceptibility. Basic Clin Pharmacol Toxicol 2021;129:196-209. [PMID: 34117726 DOI: 10.1111/bcpt.13622] [Reference Citation Analysis]
8 Lin S, Xu X, Hu H, Cheng J, Chen R, Hu Y, Chen X. The expression profile of platelet-derived miRNA in coronary artery disease patients with clopidogrel resistance. Pharmacol Res Perspect 2021;9:e00751. [PMID: 33724726 DOI: 10.1002/prp2.751] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Sukmawan R, Hoetama E, Suridanda Danny S, Giantini A, Listiyaningsih E, Gilang Rejeki V, Aziz Alkatiri A, Firdaus I. Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI). Pharmacol Res Perspect 2021;9:e00738. [PMID: 33641235 DOI: 10.1002/prp2.738] [Reference Citation Analysis]
10 Wysocka A, Zwolak A. The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases. Int J Mol Sci 2021;22:2137. [PMID: 33670025 DOI: 10.3390/ijms22042137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yang J, Yu Q, Xu Z, Zheng N, Zhong J, Li J, Liu Y, Xu H, Su J, Ji L, Chen X. Clopidogrel Resistance Is Associated With DNA Methylation of Genes From Whole Blood of Humans. Front Genet 2020;11:583215. [PMID: 33519892 DOI: 10.3389/fgene.2020.583215] [Reference Citation Analysis]
12 Li X, Wu N, Ji H, Huang Y, Hu H, Li J, Mi S, Duan S, Chen X. A male-specific association between AGTR1 hypermethylation and coronary heart disease. Bosn J Basic Med Sci 2020;20:31-6. [PMID: 31538912 DOI: 10.17305/bjbms.2019.4321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zhang Z, Chen M, Zhang L, Zhao Q. The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention. BMC Pharmacol Toxicol 2020;21:1. [PMID: 31900240 DOI: 10.1186/s40360-019-0378-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
14 Su J, Zheng N, Li Z, Huangfu N, Mei L, Xu X, Zhang L, Chen X. Association of GCK gene DNA methylation with the risk of clopidogrel resistance in acute coronary syndrome patients. J Clin Lab Anal 2020;34:e23040. [PMID: 31605429 DOI: 10.1002/jcla.23040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Su J, Li J, Yu Q, Xu X, Wang J, Yang J, Li X, Chen X. Association of PON1 gene promoter DNA methylation with the risk of Clopidogrel resistance in patients with coronary artery disease. J Clin Lab Anal 2019;33:e22867. [PMID: 30891852 DOI: 10.1002/jcla.22867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]